- 更多网络例句与可以再度使用的相关的网络例句 [注：此内容来源于网络，仅供参考]
-
Previously, Dr. Mahon and colleagues conducted a pilot study and explored the feasibility of discontinuing imatinib in CML patients who had experienced a complete molecular response. Of the 15 patients included in the cohort, 7 relapsed within 6 months, but they were able to reattain a complete molecular response after imatinib was restarted. The other 8 patients remain in remission after the discontinuation of imatinib (median follow-up is 37 months).
之前，Mahon医师等人主导一个先驱研究，探索完整分子生物学上缓解之CML病患停用imatinib的可能性，在总共15名病患中，7人在6个月内復发，但他们可以在再度使用imatinib之后再度达到完整分子生物学上缓解，其他8个病患在停用imatinib之后持续缓解(平均追踪期为37个月)。
-
Previously, Dr. Mahon and colleagues conducted a pilot study and explored the feasibility of discontinuing imatinib in CML patients who had experienced a complete molecular response. Of the 15 patients included in the cohort, 7 relapsed within 6 months, but they were able to reattain a complete molecular response after imatinib was restarted. The other 8 patients remain in remission after the discontinuation of imatinib (median follow-up is 37 months).
之前，Mahon医师等人主导一个先驱研究，探索完整分子生物学上缓解之CML病患停用imatinib的可能性，在总共15名病患中，7人在6个月内复发，但他们可以在再度使用imatinib之后再度达到完整分子生物学上缓解，其他8个病患在停用imatinib之后持续缓解(平均追踪期为37个月)。
-
Previously, Dr. Mahon and colleagues conducted a pilot study and explored the feasibility of discontinuing imatinib in CML patients who had experienced a complete molecular response. Of the 15 patients included in the cohort, 7 relapsed within 6 months, but they were able to reattain a complete molecular response after imatinib was restarted. The other 8 patients remain in remission after the discontinuation of imatinib (median follow-up is 37 months).
之前，Mahon医师等人主导一个先驱研究，探索完整分子生物学上缓解之CML病患停用imatinib的可能性，在总共15名病患中，7人在6个月内复发，但他们可以在再度使用imatinib之后再度达到完整分子生物学上缓解，其它8个病患在停用imatinib之后持续缓解(平均追踪期为37个月)。
- 更多网络解释与可以再度使用的相关的网络解释 [注：此内容来源于网络，仅供参考]
-
symbols：标志
这器皿可以更舒适如果在其身体复合体下方给予更多支撑. 除此之外, 我们只能再度请求仔细地校准使用的标志(symbols) 使器皿更容易保持平衡. 我们的通讯是窄频的, 因此带入我们的汇流必须很精准.